varicella-zoster%20virus%20infection
VARICELLA-ZOSTER VIRUS INFECTION
Varicella, also known as chickenpox, is a self-limited benign disease caused by primary varicella-zoster virus (VZV) infection characterized by fever, malaise, and generalized pruritic vesicular rash.
The average incubation period is 14-16 days. It is transmitted via direct contact with vesicular fluid or inhalation of aerosolized respiratory secretions or via droplet route during face-to-face contact.
Hallmark sign is pruritic rash that begins in the scalp and face which eventually spreads to the trunks and extremities.

Varicella-Zoster Virus Infection Drug Information

Drug Information

Indication: Vaccination against varicella in individuals ≥12 mth.

Indication: Prevention of herpes zoster (shingles) & postherpetic neuralgia; reduction of acute & chronic zoster-a...

Indication: Treatment & prevention of herpes simplex virus infections, genital herpes of skin & mucous membranes &...

Indication: HSV skin infections including initial & recurrent genital herpes labialis.

Indication: Herpes simplex virus infections of skin & mucous membranes including initial & recurrent genital herpe...

Indication: HSV skin infection including genital herpes & herpes labialis.

Indication: Herpes zoster. Accelerates resolution of pain by reducing duration & proportion of patients w/ zoster-asso...

Indication: Promoting resolution of acute clinical manifestations of mucocutaneous HSV infections in immunocompromised pat...

Indication: Herpes simplex skin & mucous membrane infections including initial & recurrent genital herpes. Suppres...

Indication: Treatment & prophylaxis of herpes genitalis, treatment of herpes zoster, herpes simples & varicella (c...

1  /  4
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Infectious Diseases - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 01 Dec 2020

An evidence-based, multifaceted intervention aimed at reducing haemodialysis catheter-related bloodstream infections (HD-CRBSIs) failed to improve this outcome, results of the REDUCCTION* trial showed.

Pearl Toh, 3 days ago
While it is well known that COVID-19 illness is associated with coagulopathy, the optimal anticoagulation strategy remains elusive, and two studies presented at the ASH 2020 Congress further add to the growing debate on the appropriate anticoagulant dose for hospitalized patients with COVID-19.
Tristan Manalac, 20 hours ago
People are more likely to follow social distancing measures for the novel coronavirus disease (COVID-19) pandemic when they thought that their friends and family did the same, too, according to a new study.